136 related articles for article (PubMed ID: 37846683)
1. [Clinical Characteristics and Long-Term Survival of Patients with Chronic Lymphocytic Leukemia].
Ma L; Li Y; Wang JJ; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1345-1351. PubMed ID: 37846683
[TBL] [Abstract][Full Text] [Related]
2. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
3. Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies.
Langerbeins P; Giza A; Robrecht S; Cramer P; von Tresckow J; Al-Sawaf O; Fink AM; Fürstenau M; Kutsch N; Simon F; Goede V; Hoechstetter M; Niemann CU; da Cunha-Bang C; Kater A; Dubois J; Gregor M; Staber PB; Tausch E; Schneider C; Stilgenbauer S; Eichhorst B; Fischer K; Hallek M
Blood; 2024 Jun; 143(25):2588-2598. PubMed ID: 38620092
[TBL] [Abstract][Full Text] [Related]
4. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of CLL-IPI for Chinese patients with chronic lymphocytic leukemia].
Zhu HY; Wang L; Qiao J; Zou YX; Xia Y; Wu W; Cao L; Liang JH; Fan L; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):392-397. PubMed ID: 29779348
[No Abstract] [Full Text] [Related]
6. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.
Takahashi K; Hu B; Wang F; Yan Y; Kim E; Vitale C; Patel KP; Strati P; Gumbs C; Little L; Tippen S; Song X; Zhang J; Jain N; Thompson P; Garcia-Manero G; Kantarjian H; Estrov Z; Do KA; Keating M; Burger JA; Wierda WG; Futreal PA; Ferrajoli A
Blood; 2018 Apr; 131(16):1820-1832. PubMed ID: 29358183
[TBL] [Abstract][Full Text] [Related]
8. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F
Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919
[TBL] [Abstract][Full Text] [Related]
9. Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks.
Turcsanyi P; Kriegova E; Kudelka M; Radvansky M; Kruzova L; Urbanova R; Schneiderova P; Urbankova H; Papajik T
Leuk Res; 2019 Apr; 79():60-68. PubMed ID: 30852300
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients].
Sha YQ; Shen H; Wu W; Xia Y; Miao Y; Cao L; Wang L; Fan L; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):834-839. PubMed ID: 34788923
[No Abstract] [Full Text] [Related]
11. [Survival analysis of 118 chronic lymphocytic leukemia patients with abnormal TP53 gene in the era of traditional immunochemotherapy].
Li XT; Zhu HY; Wang L; Xia Y; Liang JH; Wu JZ; Wu W; Cao L; Fan L; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):378-383. PubMed ID: 31207701
[No Abstract] [Full Text] [Related]
12. Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.
Soumerai JD; Ni A; Xing G; Huang J; Furman RR; Jones J; Sharman JP; Hallek M; Adewoye AH; Dubowy R; Dreiling L; Zelenetz AD
Leuk Lymphoma; 2019 Jun; 60(6):1438-1446. PubMed ID: 30407886
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.
Chan TS; Lee YS; Del Giudice I; Marinelli M; Ilari C; Cafforio L; Guarini A; Tan D; Phipps C; Goh YT; Hwang W; Goh AZ; Siu LL; Wu S; Ha CY; Lin SY; Kwok CH; Lau CK; Wong KF; Foà R; Kwong YL; Tse E
Oncotarget; 2017 Apr; 8(15):25455-25468. PubMed ID: 28424415
[TBL] [Abstract][Full Text] [Related]
14. The percentage of cells with 17p deletion and the size of 17p deletion subclones show prognostic significance in chronic lymphocytic leukemia.
Yuan YY; Zhu HY; Wu JZ; Xia Y; Liang JH; Wu W; Cao L; Wang L; Fan L; Li JY; Xu W
Genes Chromosomes Cancer; 2019 Jan; 58(1):43-51. PubMed ID: 30350431
[TBL] [Abstract][Full Text] [Related]
15. The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Parikh SA; Rabe KG; Kay NE; Call TG; Ding W; Leis JF; Kenderian SS; Muchtar E; Wang Y; Koehler AB; Schwager SM; Lesnick CE; Kleinstern G; Van Dyke D; Hanson CA; Braggio E; Slager SL; Shanafelt TD
Blood; 2021 Jul; 138(2):149-159. PubMed ID: 33876228
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of CLL-IPI scoring system in Pakistani Chronic Lymphocytic Patients: A single center experience.
Hameed A; Sajid N; Fayyaz M; Khaliq S
Pak J Med Sci; 2024; 40(4):701-705. PubMed ID: 38545024
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
Hallek M
Am J Hematol; 2017 Sep; 92(9):946-965. PubMed ID: 28782884
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study.
Lai YY; Huang XJ
Chin Med J (Engl); 2011 Aug; 124(16):2417-22. PubMed ID: 21933580
[TBL] [Abstract][Full Text] [Related]
19. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
Brieghel C; Galle V; Agius R; da Cunha-Bang C; Andersen MA; Vlummens P; Mattsson M; Rosenquist R; Smedby KE; Herling CD; Bahlo J; Hallek M; Lundgren JD; Offner F; Niemann CU
Eur J Haematol; 2022 May; 108(5):369-378. PubMed ID: 35030282
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes.
Collado R; Puiggros A; López-Guerrero JA; Calasanz MJ; Larráyoz MJ; Ivars D; García-Casado Z; Abella E; Orero MT; Talavera E; Oliveira AC; Hernández-Rivas JM; Hernández-Sánchez M; Luño E; Valiente A; Grau J; Portal I; Gardella S; Salgado AC; Giménez MT; Ardanaz MT; Campeny A; Hernández JJ; Álvarez S; Espinet B; Carbonell F
Cancer Lett; 2017 Nov; 409():42-48. PubMed ID: 28888994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]